TrialJournal of diabetes research2022

Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China.

Hao Zhaohu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.